Mom Charged in Ketoacidosis Death; 15-Day CGM Launches Soon; Long-Acting GLP-1 Win​Mom Charged in Ketoacidosis Death; 15-Day CGM Launches Soon; Long-Acting GLP-1 Win 

(MedPage Today) — A mother was charged with manslaughter after her 10-year-old daughter with type 1 diabetes died from prolonged diabetic ketoacidosis while on a summer road trip. (New York Times) Metformin failed to improve liver, muscle, and… ​ (MedPage Today) — A mother was charged with manslaughter after her 10-year-old daughter with type 1 Read More

Lesser-Known Lobular Breast Cancer on the Rise​Lesser-Known Lobular Breast Cancer on the Rise 

Invasive lobular carcinoma is now increasing faster than other types of breast cancers among US women. A recent study published in Cancer found that new cases of lobular breast cancer, which originates in the milk-producing glands, are climbing at a rate of nearly 3% per year, compared with less than 1% for all other breast cancers combined. As of 2021, 14 cases per 100 000 women with invasive lobular carcinoma have been reported, which accounted for 10% of breast cancer cases.

Highly Anticipated Alzheimer’s Trials Yield Disappointing Results for GLP-1 Drug​Highly Anticipated Alzheimer’s Trials Yield Disappointing Results for GLP-1 Drug 

(MedPage Today) — The oral GLP-1 receptor agonist semaglutide (Rybelsus) did not slow Alzheimer’s disease progression in the highly awaited EVOKE phase III trials, Novo Nordisk announced Monday. The company shared topline results from the 2-year… ​ (MedPage Today) — The oral GLP-1 receptor agonist semaglutide (Rybelsus) did not slow Alzheimer’s disease progression in the Read More